Colorectal Cancer 2 of 3 - Pathophysiology, Epidemiology and Clinical Evaluation
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
Colorectal Cancer 2 of 3 - Pathophysiology, Genetics and Clinical EvaluationHereditary Colorectal Cancer Syndromes and Genetic PredispositionsThe second segment would transition into the genetic roots of the disease, focusing on how 10% of CRC cases are tied to inherited genetic syndromes. The discussion should heavily feature high-penetrance conditions like Lynch syndrome—the most common hereditary cause driven by mismatch repair (MMR) gene mutations—and Familial Adenomatous Polyposis (FAP), which coats the colon in hundreds of precancerous polyps. The hosts can also touch upon rarer syndromes, such as Peutz-Jeghers and Li-Fraumeni, emphasizing how these inherited mutations drastically increase lifetime risks for multiple types of cancer.
- Lynch syndrome is the most prevalent hereditary CRC, conferring up to an 80% lifetime risk of colon cancer alongside heightened risks for endometrial and other cancers.
- FAP is caused by APC gene mutations, leading to massive polyp growth and nearly a 90% CRC risk by age 45 without surgical intervention.
- MUTYH-associated polyposis (MAP) is an autosomal recessive condition causing attenuated polyposis and early-onset CRC, averaging onset at age 46.
- Moderate-penetrance mutations in genes like CHEK2 and ATM slightly elevate CRC risk while significantly raising susceptibility to breast, prostate, and stomach cancers
No reviews yet